The United Kingdom National Health Service is a high-quality health care system, providing a comprehensive service to 59 million people, which also has the potential to serve as a unique resource for population genetics research. Capitalizing on the, as yet, untapped value will require appropriate scientific and clinical skills matched with large-scale computational infrastructure and proactive, transparent, and coherent policies for addressing the ethical, legal, social, and political issues arising from the use of clinical information. Public-private partnership is essential to maximize this opportunity to ensure that the clinical benefits of genetic epidemiology are realized and forge the evolution of increasingly rational care.
No takes yet. Share an insight, caveat, or question.
Fears et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: